Sophion to Sell CHO-hERG Cell Line Optimized for the QPatch Automated Patch Clamp System

Sophion Bioscience A/S has announced an agreement with bSys, Switzerland that allows Sophion to sell a CHO-hERG cell line fully optimized for and validated on the QPatch automated patch clamp system. The cell line was created by bSys and further developed by scientists at Sophion. These cells, marketed by Sophion as "CHO-hERG DUO" cells, are being sold to existing and new customers to maximize the quality and throughput of ion channel screening with the QPatch. By offering the CHO-hERG DUO cell line Sophion strengthen its position as a complete solution provider.

Automated patch clamp studies depend, to a great extent, on the quality of tissue culture cells used during experiments. Cells optimized for peak performance on the QPatch more readily achieve gigaohm seals and successful whole-cell recordings. Furthermore, all cells express enough ion channel protein for measurable whole cell currents, giving the maximal success rate possible.

For further information please contact:

Torsten Freltoft,

CEO

Tel: +45 44 60 88 00

Email: tof@sophion.dk

Or visit: www.sophion.com